Nuveen Asset Management, LLC - GALENA BIOPHARMA INC ownership

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q3 2016$4,000
-33.3%
12,1360.0%0.00%
Q2 2016$6,000
-62.5%
12,136
+4.9%
0.00%
Q1 2016$16,000
-5.9%
11,5720.0%0.00%
Q4 2015$17,000
-5.6%
11,5720.0%0.00%
Q3 2015$18,000
-10.0%
11,5720.0%0.00%
Q2 2015$20,000
+25.0%
11,5720.0%0.00%
Q1 2015$16,00011,5720.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Hoxton Financial, Inc. 50,000$74,0000.04%
Alyeska Investment Group, L.P. 1,593,277$2,342,0000.02%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 31,000$46,0000.02%
GROUP ONE TRADING, L.P. 1,346,904$1,980,0000.02%
Matisse Capital 17,000$25,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 15,000$22,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 12,150$18,0000.01%
EQUITEC SPECIALISTS, LLC 19,700$29,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 153,375$225,0000.00%
OPPENHEIMER & CO INC 94,300$138,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders